Xiuqian Mu, MD, PhD, professor of ophthalmology at the Jacobs School of Medicine and Biomedical Sciences, has received additional funding from the National Eye Institute for his research on retinal ...

Researchers in the WashU Medicine Department of Ophthalmology & Visual Sciences have discovered key neuroprotective genes ...

Edward Kang’s RetinaMind analyzes patients’ retinal images and accurately diagnoses neurodevelopmental disorders 89 percent ...

Curacle licenses retinal antibody MT-103 to US Memento in $1.08b deal Memento gains exclusive global rights to MT-103 as ...

Beacon is investigating the gene therapy in other pivotal trials, including the VISTA trial that is expected to readout in H2 ...

“When we talk about language, in particular, what’s really important is usage. Hearing language is one thing, but actually ...

Postdoctoral researcher Kamal Shokeen at the Albert Einstein College of Medicine studies how a key protein guides retinal ...

Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") today announced new research insights for geographic atrophy (GA) that will be presented at the Association for ...

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing ...

We are delighted by the Breakthrough award, but we accept it representing this brilliant team of people at Penn,” Bennett ...

Ocugen faces a packed 2026-27 catalyst window with filings, interim data and Phase III readouts across three one-time retinal gene therapies.

Latest stories by Reghu Balakrishnan. Reghu Balakrishnan writes for ETHealthworld.com and gives views & updates on the Indian Health industry.